Legal & General Group PLC Albireo Pharma, Inc. Transaction History

Legal & General Group PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$18.01 - $23.78 $7,816 - $10,320	434 Added 6.62%	6,990 $151,000
Q3 2022 Nov 14, 2022	BUY	$16.32 - $26.37 $3,574 - $5,775	219 Added 3.46%	6,556 $127,000
Q2 2022 Aug 22, 2022	BUY	$18.54 - $37.29 $4,041 - $8,129	218 Added 3.56%	6,337 $126,000
Q1 2022 May 16, 2022	BUY	$23.94 - $33.74 $12,712 - $17,915	531 Added 9.5%	6,119 $183,000
Q3 2021 Nov 15, 2021	BUY	$27.36 - $35.98 $82,681 - $108,731	3,022 Added 117.77%	5,588 $175,000
Q2 2021 Aug 12, 2021	SELL	$28.9 - $36.87 $7,687 - $9,807	-266 Reduced 9.39%	2,566 $90,000
Q1 2021 May 17, 2021	BUY	$32.03 - $42.85 $4,772 - $6,384	149 Added 5.55%	2,832 $100,000
Q4 2020 Feb 12, 2021	BUY	$31.56 - $42.16 $37,651 - $50,296	1,193 Added 80.07%	2,683 $100,000
Q3 2020 Nov 13, 2020	SELL	$23.19 - $41.61 $11,826 - $21,221	-510 Reduced 25.5%	1,490 $50,000
Q2 2020 Aug 14, 2020	SELL	$14.82 - $29.92 $904 - $1,825	-61 Reduced 2.96%	2,000 $53,000
Q1 2020 May 14, 2020	SELL	$11.67 - $27.23 $3,536 - $8,250	-303 Reduced 12.82%	2,061 $34,000
Q4 2019 Feb 13, 2020	BUY	$16.92 - $28.96 $7,123 - $12,192	421 Added 21.67%	2,364 $60,000
Q3 2019 Nov 13, 2019	BUY	$20.0 - $31.88 $6,200 - $9,882	310 Added 18.98%	1,943 $39,000
Q1 2019 May 15, 2019	BUY	$22.22 - $32.21 $6,088 - $8,825	274 Added 20.16%	1,633 $53,000
Q2 2018 Aug 10, 2018	BUY	$28.9 - $37.31 $39,275 - $50,704	1,359 New	1,359 $48,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.